Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 2,370 | 2,380 |
| Gross Profit | 2,370 | 2,380 |
| Operating Expenses | 80,134 | 42,494 |
| Operating Income | -77,764 | -40,114 |
| Other Income | 14,958 | 19,577 |
| Pre-tax Income | -62,806 | -20,537 |
| Net Income Continuous | -62,806 | -20,537 |
| Net Income | $-62,806 | $-20,537 |
| EPS Basic Total Ops | -5.58 | -12.95 |
| EPS Basic Continuous Ops | -4.59 | -6.95 |
| EPS Diluted Total Ops | -5.58 | -12.95 |
| EPS Diluted Continuous Ops | -4.59 | -6.95 |
| EPS Diluted Before Non-Recurring Items | -5.58 | N/A |
| EBITDA(a) | $-79,330 | $-41,314 |